ndia has announced a goal of universal access to quality tuberculosis (TB) diagnosis and treatment. A number of novel diagnostics could help meet this important goal. The rollout of one such diagnostic, Xpert MTB/RIF (Xpert) is being considered, but if Xpert is used mainly for people with HIV or high risk of multidrug-resistant TB (MDR-TB) in the public sector, population-level impact may be limited.
The new consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations bring together all existing World Health Organization (WHO) guidance relevant to five key populations (both
Posing a huge threat to the public health, nearly 6000 unregistered collection centres are functional in Kashmir Valley.
The collection centers are opened at various pharmacies and clinics of doctors. The samples for various blood and related tests are collected at these centres and mostly send outside Kashmir for examinations.
Taking a malaria control program from the control phases through to elimination is challenging. The reorientation of the malaria control program involves a shift of focus, from reaching high levels of coverage of interventions to prevent morbidity and mortality, to an emphasis on completeness and timeliness of activities in order to seek out infections and interrupt transmission. The need to communicate this change in strategic thinking to large, cumbersome health systems has proven a challenge. Has China found a solution?
The recent emergence of Zaire ebolavirus in West Africa has come as a surprise in a region more commonly known for its endemic Lassa fever, another viral hemorrhagic fever caused by an Old World arenavirus. Yet the region has seen previous ebolavirus activity. In the mid-1990s, scientists discovered Côte d'Ivoire ebolavirus (now known as Taï Forest ebolavirus) as a cause of a single reported nonfatal case in a researcher who performed a necropsy on an infected chimpanzee.
